BCDA
BCDA
NASDAQ · Biotechnology

Biocardia Inc

$1.04
-0.01 (-0.95%)
As of Sep 28, 10:40 PM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +3,165.4% upside
Low Target $19.62
Average Target $33.96
High Target $35.69
Current Price $1.04
Current
$1.04
Target
$33.96
$19.62 $33.96 avg $35.69
Scenario Analysis
Bear Case
$19.62
1,786.5%
Low target
Base Case
$33.96
+3,165.4%
Avg target
Bull Case
$35.69
+3,331.7%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$1.80
-42.2% from high
52-Week Low
$0.75
+38.7% from low
Target vs 52W High
$33.96
+1,786.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -3.3%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.4%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +138.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -24.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.4%